Brightsurf Science News & Current Events

November 13, 2002
Acorda Therapeutics receives L.W. Freeman Award for Scientific Research
Acorda Therapeutics, a privately held biotechnology company developing therapies for spinal cord injury (SCI) and related neurological conditions, including multiple sclerosis, will receive the L.W.

Large-scale climate change linked to simultaneous population fluctuations in arctic mammals
The first study to show that changes in a large-scale climate system can synchronize population fluctuations in multiple mammal species across a continent-scale region will be published in the journal Nature in a study of caribou and muskoxen in Greenland.

A new twist on an age-old problem: Making knee replacements last
More than a quarter million Americans each year get new knee joints, yet only incremental advances have been made in their design since the devices were developed in the 1960s.

Maternal fever in early pregnancy not associated with fetal death
Danish authors of a study in this week's issue of The Lancet provide reassurance to pregnant women--maternal fever in the early stages of pregnancy is probably not a risk factor for miscarriage or stillbirth.

UCSD bioengineers develop first computer model that predicts disease variant based on genetic defect
University of California, San Diego (UCSD) Bioengineers have for the first time used a computer model to relate specific genetic mutations to exact variations of a disease.

UCLA scientists eavesdrop on cellular conversations by making mice 'glow' with firefly protein
UCLA scientists coupled the protein that makes fireflies glow with a device similar to a home video camera to eavesdrop on cellular conversations in living mice.

New evidence that El Niño influences global climate conditions on a 2,000-year cycle
El Niño, the pattern that can wreak havoc on climate conditions around the world, is like a beacon, pulsating through time on a 2,000 year cycle, according to a new study by scientists from Syracuse University, Syracuse, N.Y.; Union College, Schenectady, N.Y., and from the NOAA Paleoclimatology Program, Boulder, Colo., that is being published in the Nov.

Molecular tag pinpoints which breast cancer tumors are most likely to spread
A new molecular tag discovered by scientists at The University of Texas M.

University of Alberta physicist helps transfer data at world record pace
A University of Alberta physicist was part of a Canadian research team which recently set a WORLD RECORD for high-speed disk-to-disk transfer of research data.

Sepsis vaccine proves protective in preliminary studies at The Scripps Research Institute
A group of researchers from The Scripps Research Institute (TSRI) have designed a vaccine that might be used to protect against the pernicious consequences of severe sepsis, an acute and often deadly disease that is estimated to strike 700,000 Americans a year and millions more worldwide.

Non-lethal technology symposium: Nov. 19-21 in La Jolla, CA
The University of New Hampshire's Non-Lethal Technology Innovation Center (NTIC) and the Joint Non-Lethal Weapons Directorate (JNLWD) will sponsor the fourth annual Non-lethal Technology and Academic Research (NTAR IV) Symposium at the San Diego Marriott in La Jolla, California.

OSU, PNNL join forces in new microproducts institute
Oregon State University and the Department of Energy's Pacific Northwest National Laboratory today agreed to form a research and educational center, called the Microproducts Breakthrough Institute, to develop and help market advances in the emerging and highly promising field of microtechnology.

Bias still exists but adoption is a viable option for homosexuals
Discrimination based on sexual orientation still exists, but many adoption agencies are open to placing children with gay and lesbian parents, according to researchers at Rutgers, The State University of New Jersey.

Acorda Therapeutics acquires CeNeS neuregulin products
Following its goals to develop therapies for spinal cord injury (SCI) and related neurological conditions, including multiple sclerosis (MS), Acorda Therapeutics has acquired an exclusive worldwide license from CeNeS plc (LSE: CEN) to its glial growth factor 2 (GGF2)and neuregulin 2 (NRG2) products, which have demonstrated nerve repair abilities, specifically remyelination.

Microorganisms are cleaning up Boston Harbor, UMass study finds
Microorganisms are cleaning up contaminants in the mud beneath Boston Harbor, and if humans prevent future fuel spills, the harbor could potentially cleanse itself within 10 to 20 years, according to research conducted at the University of Massachusetts Amherst.

Detecting bacteria in space: The good, the bad and the unknown
Bacteria in space, beware. New technology to monitor and identify bacteria and to characterize unknown bacteria is in the works through research funded by the National Space Biomedical Research Institute.

Rutgers-Newark research advances electrical imaging to assess pollution control technology
Lee Slater, assistant professor in the department of earth and environmental science at Rutgers-Newark, is using electrical imaging for the first time nationally to assess the performance of new groundwater pollution-control technology.

Los Alamos' Sattelberger elected AAAS Fellow
The leader of Los Alamos' Chemistry Division, Alfred P. Sattelberger, was elected a Fellow by the AAAS Council for his

New HIV vaccine holds promise of global effectiveness
Clinical tests began today of a novel vaccine directed at the three most globally important HIV subtypes, or clades.

Six reporters named to receive 2002 AAAS Science Journalism Awards
A broadcast program on is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to